Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.47 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | BID | P55957 | 3/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.45 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.45 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.45 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4829328 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5271594 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28250901 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL196431 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5599139 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3694247 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL19391066 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11658176 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31444780 | 1.00 | LIPG (0.58) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31445158 | 0.98 | LIPG (0.56) | LIPGTAAR1SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1312605-B1 | Method for producing biaryl compounds | SUMITOMO CHEMICAL CO (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-7122711-B2 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-10-17 | — | — | US | disclosed |
| US-20030158419-A1 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-08-21 | — | — | US | disclosed |
| EP-1312605-A1 | Method for producing biaryl compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-21 | — | — | EP | disclosed |
| US-4538003-A | TREATMENT WITH MAGNESIUM OR ZINC ORGANOMETALLIC REAGENTS IN PRESENE OF A NICKEL BIDENTATE OR TRIDENTATE PHOSPHOROUS LIGAND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| US-4235838-A | IN OIL AND GAS WELLS | PETROLITE CORPORATION (US) | 1980-11-25 | — | — | US | disclosed |
| US-4162339-A | Newsprint coupon separator | HUNKINS JAMES (US) | 1979-07-24 | — | — | US | disclosed |
| US-4073982-A | DEMARCATION | WECK FRIEDRICH J | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158419-A1 | Method for producing biaryl compound | B2M, BMI1, CYP2W1 | LIPG 2599/4885TAAR1 1971/4885SLC6A2 3899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.